Improve Research Reproducibility A Bio-protocol resource
- Home
- Protocols
-
Ask a
question
Favorite
Detection of genetic alterations at primary tumor sites, such as epidermal growth factor receptor (EGFR) mutations, anaplastic lymphoma kinase (ALK) rearrangement, cellular‐mesenchymal to epithelial transition factor (c‐MET) amplification, and ROS proto‐oncogene 1 (ROS1) rearrangements were acquired using state‐of‐the‐art methods, including the amplification refractory mutation system, fluorescence in situ hybridization, and next‐generation sequencing.
Copyright and License information: ©2022 The Authors. published by China Lung Oncology Group and John Wiley & Sons Australia, Ltd.
This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.
Post a Question0 Q&A
